Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Leibold JS"'
Autor:
Ayline Kübler, Bühring Hj, Leibold Js, Ludger Grosse-Hovest, Kousis Pc, Gundram Jung, Sebastian P. Haen, Maya C. André, Helmut R. Salih, Samuel Koerner, Marina Pal
Publikováno v:
Leukemia. 31(2)
Antibody-dependent cellular cytotoxicity (ADCC) of natural killer (NK) cells largely contributes to the success of monoclonal antibody (mAb) treatment in cancer. As no antibodies are clinically available for immunotherapy of myeloid leukemias (MLs),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16398d2a8cb54c3adb62942f07cc3111
https://pubmed.ncbi.nlm.nih.gov/27435001
https://pubmed.ncbi.nlm.nih.gov/27435001
Autor:
Koerner SP; Department for Internal Medicine II, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tuebingen, Germany.; Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany., André MC; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University, Tuebingen, Germany.; Department of Pediatric Intensive Care, University Children's Hospital, Basel, Switzerland., Leibold JS; Department for Immunology, Eberhard Karls University, Tuebingen, Germany., Kousis PC; Department for Internal Medicine II, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tuebingen, Germany.; Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany., Kübler A; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Pal M; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University, Tuebingen, Germany., Haen SP; Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany.; Department for Immunology, Eberhard Karls University, Tuebingen, Germany., Bühring HJ; Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany., Grosse-Hovest L; Department for Immunology, Eberhard Karls University, Tuebingen, Germany., Jung G; Department for Immunology, Eberhard Karls University, Tuebingen, Germany., Salih HR; Department for Internal Medicine II, Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Tuebingen, Germany.; Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany.
Publikováno v:
Leukemia [Leukemia] 2017 Feb; Vol. 31 (2), pp. 459-469. Date of Electronic Publication: 2016 Jul 20.
Autor:
Leibold JS; Division Signal Transduction and Growth Control, German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, Heidelberg, Germany., Riehl A; Division Signal Transduction and Growth Control, German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, Heidelberg, Germany., Hettinger J; Junior Research Group Immune Tolerance, Tumor Immunology Program, German Cancer Research Center (DKFZ), Heidelberg, Germany., Durben M; Department of Immunology, Eberhard-Karls University, Tübingen, Germany., Hess J; Junior Research Group Molecular Mechanisms of Head and Neck Tumors, German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, Heidelberg, Germany; Experimental Head and Neck Oncology, Department of Otolaryngology, Head and Neck Surgery, University Hospital, Heidelberg, Germany. Electronic address: jochen.hess@med.uni-heidelberg.de., Angel P; Division Signal Transduction and Growth Control, German Cancer Research Center (DKFZ), DKFZ-ZMBH Alliance, Heidelberg, Germany.
Publikováno v:
The Journal of investigative dermatology [J Invest Dermatol] 2013 Oct; Vol. 133 (10), pp. 2400-2406. Date of Electronic Publication: 2013 Apr 17.